Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trialsCathrine Axfors, Franca Danielle, Владимир П. Баклаушев et al.|BMC Infectious Diseases|2021Cited by 70
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection–Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective StudyAntonio Muscatello, Alessandra Bandera, Silvia Nozza et al.|Pathogens and Immunity|2020Cited by 25
Pillars of long-term antiretroviral therapy successLucia Taramasso, Franco Maggiolo, Massimo Andreoni et al.|Pharmacological Research|2023Cited by 22
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona CohortRoberta Gagliardini, Stefano Bonora, S De Benedittis et al.|Journal of Antimicrobial Chemotherapy|2025Cited by 15
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohortAntonella d’Arminio Monforte, Carlo Torti, Alessandro Tavelli et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 9